BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19493372)

  • 1. Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias.
    Rempel OR; Laupland KB
    Epidemiol Infect; 2009 Dec; 137(12):1665-73. PubMed ID: 19493372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance and future of antimicrobial surveillance studies.
    Masterton R
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S21-31. PubMed ID: 18713046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations.
    Santos RP; Mayo TW; Siegel JD
    Clin Infect Dis; 2008 Jul; 47(1):110-6. PubMed ID: 18491966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European recommendations for antimicrobial resistance surveillance.
    Cornaglia G; Hryniewicz W; Jarlier V; Kahlmeter G; Mittermayer H; Stratchounski L; Baquero F;
    Clin Microbiol Infect; 2004 Apr; 10(4):349-83. PubMed ID: 15059129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological interpretation of antibiotic resistance studies - what are we missing?
    Schwaber MJ; De-Medina T; Carmeli Y
    Nat Rev Microbiol; 2004 Dec; 2(12):979-83. PubMed ID: 15550943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk scoring for setting priorities in a monitoring of antimicrobial resistance in meat and meat products.
    Presi P; Stärk KD; Stephan R; Breidenbach E; Frey J; Regula G
    Int J Food Microbiol; 2009 Mar; 130(2):94-100. PubMed ID: 19168250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
    Payne D; Tomasz A
    Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging antimicrobial-resistant infections.
    Roos KL
    Arch Neurol; 2004 Oct; 61(10):1512-4. PubMed ID: 15477503
    [No Abstract]   [Full Text] [Related]  

  • 9. The relentless rise of resistance?
    Wise R
    J Antimicrob Chemother; 2004 Aug; 54(2):306-10. PubMed ID: 15231764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center - 6 years' experience.
    Lee CY; Chen PY; Huang FL; Lin CF
    J Microbiol Immunol Infect; 2009 Apr; 42(2):160-5. PubMed ID: 19597649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing antimicrobial resistance through appropriate antibiotic usage in Singapore.
    Hsu LY; Kwa AL; Lye DC; Chlebicki MP; Tan TY; Ling ML; Wong SY; Goh LG
    Singapore Med J; 2008 Oct; 49(10):749-55. PubMed ID: 18946605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting antibiotic resistance.
    Martínez JL; Baquero F; Andersson DI
    Nat Rev Microbiol; 2007 Dec; 5(12):958-65. PubMed ID: 18007678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
    Rolston KV
    Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stakeholder position paper: epidemiological perspectives on antibiotic use in animals.
    Singer RS; Reid-Smith R; Sischo WM
    Prev Vet Med; 2006 Feb; 73(2-3):153-61. PubMed ID: 16257465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance.
    Clarke CR
    Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):987-1001, vi. PubMed ID: 16984824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of mathematical modeling to the fight against bacterial antibiotic resistance.
    Opatowski L; Guillemot D; Boëlle PY; Temime L
    Curr Opin Infect Dis; 2011 Jun; 24(3):279-87. PubMed ID: 21467930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving concepts of pharmaceutical company-sponsored surveillance studies.
    Koeth LM; Miller LA
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S279-82. PubMed ID: 16032566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the antibacterial resistance crisis.
    Croft AC; D'Antoni AV; Terzulli SL
    Med Sci Monit; 2007 Jun; 13(6):RA103-18. PubMed ID: 17534243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for control of antimicrobial resistance.
    Tacconelli E; Sifakis F; Harbarth S; Schrijver R; van Mourik M; Voss A; Sharland M; Rajendran NB; Rodríguez-Baño J;
    Lancet Infect Dis; 2018 Mar; 18(3):e99-e106. PubMed ID: 29102325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is inadequate antibacterial therapy?
    Moellering RC
    Clin Infect Dis; 2009 Oct; 49(7):1006-8. PubMed ID: 19719418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.